Board of Directors of Extendicare Inc.
Alan D. Torrie (GN) (HR) Independent Director, Non-executive Chairman, Chair of the Governance and Nominating Committee
Mr. Torrie was appointed Chairman of the Board on May 25, 2017. He is a former President and CEO of Morneau Shepell Inc. (Morneau Shepell) (from 2008 to May 2017), and a former member of its board from 2005 to 2017. A TSX listed company, Morneau Shepell is a leading provider of Employee and Family Assistance Programs, the largest administrator of pension and benefits plans and the largest provider of integrated absence management solutions in Canada.
Mr. Torrie has over 30 years of experience as a senior executive leader in health care and life sciences, including as Chief Operating Officer of Retirement Residences REIT, or “RRR”, from 2005 to 2007 (a predecessor of Revera Inc.), and in a number of senior executive positions at MDS Inc. (a predecessor of Nordion Inc.) from 1987 to 2005, including as President and CEO of MDS Diagnostics and MDS Laboratories (1999 to 2003). He has also served as the President and Chief Executive Officer of Discovery Air Inc. (August 2017 to September 2018), as Executive-in-Residence with Clairvest Private Equity, a Toronto-based private equity management firm, and earlier in his career as the President and CEO of Joseph Brant Hospital and Chief Operating Officer and Vice President of Humber Memorial Hospital.
Mr. Torrie has served on numerous corporate and community boards, and is currently a director and Chair of the Audit Committee of Flow Capital (TSXV: FW) and Chair of Green Shield Canada. In addition, he previously served on the boards of Appleby College, as Chair of its Finance Committee; Trillium Health Partners, as its Chair; and Cynapsus Therapeutics Inc., as a member of its Audit Committee.
Mr. Torrie holds a B.Sc in Biochemistry from McMaster University, a DHA in Healthcare Management from the University of Toronto and has completed the Advanced Management Program from Harvard University. Mr. Torrie was appointed to the Board on January 6, 2016, and he resides in Toronto, Ontario.
Norma Beauchamp (I) (QR) Independent Director
Ms. Beauchamp is a corporate director with over 30 years of health care experience in corporate and non-profit organizations, including executive positions at Bayer Healthcare (Canada and Global) and Sanofi Canada. Most recently, she served as the President and CEO of Cystic Fibrosis Canada (2014 to 2017). Throughout her career, she has been a patient advocate, working with patient and health care organizations to enhance access to care.
Ms. Beauchamp currently serves on the respective boards of Aurora Cannabis Inc. (TSX: ACB), as Chair of its Nominating and Corporate Governance Committee and a member of its Human Resources and Compensation Committee, and Dialogue, a leading Canadian telehealth service. Formerly, Ms. Beauchamp served on the respective boards of Acerus Pharmaceuticals Corporation (TSX: ASP), as Chair of its Corporate Governance and Nominating Committee and a member of its Audit Committee; Quest PharmaTech Inc. (TSXV: QPT); and prior to its acquisition by Aurora, MedReleaf as Chair of its Corporate Governance and Compensation Committee and a member of its Audit Committee.
Ms. Beauchamp gives back to her community and serves as a member of the National Research Council of Canada and on the respective boards of the Ontario Caregiver Organization and ALS Canada. She is a Regional Ambassador with Women Get on Board where she connects with women aspiring to serve on boards. In the past, she has served on the respective boards of the St. Joseph’s Health Centre Foundation, Providence Healthcare Foundation, Health Charities Coalition of Canada and the Breast Cancer Society of Canada.
Ms. Beauchamp has completed the University of Toronto’s Rotman School of Management Directors Education Program (ICD.D), and holds a Bachelor of Business Administration in Marketing from Bishop’s University. Ms. Beauchamp was appointed to the Board on May 30, 2019, and she resides in Toronto, Ontario.
Dr. Michael Guerriere Non-independent Director, President and Chief Executive Officer
Dr. Guerriere was appointed the President and CEO of Extendicare on October 22, 2018, and has been a member of the Board since March 2018. He has a diverse background with over 25 years of experience in medical practice, hospital operations, management consulting and health technology. Dr. Guerriere was Chief Strategy Officer at TELUS Health, a provider of technology services to clinical professionals, hospitals, government agencies, health authorities, pharmacies and consumers across Canada, from May 2011 to October 2018. He also served 10 years as an executive in university teaching hospitals, including as Executive Vice President and Chief Operating Officer at the University Health Network.
Dr. Guerriere has adjunct appointments in the Institute of Health Policy Management and Evaluation at the University of Toronto and the School of Health Information Science at the University of Victoria. He has served on numerous boards including Ryerson University (where he served as Chair), MediSolution Ltd. (member of audit committee), Canada Health Infoway (chair of finance committee), the Canadian Institute for Health Information, and the Institute of Clinical Evaluative Sciences.
Dr. Guerriere holds a degree in Medicine and specialty training in Internal Medicine from the University of Toronto, an MBA from the Kellogg School of Management at Northwestern University and an honorary doctorate from Ryerson University. Dr. Guerriere was appointed to the Board in March 2018, and he resides in Toronto, Ontario.
Sandra L. Hanington (A) (GN) (QR) Independent Director, Chair of the Quality and Risk Committee
Ms. Hanington is a corporate director and advisor, and is a former President and CEO of the Royal Canadian Mint (February 2015 to July 2018). From 1999 to 2011, she held a number of progressively senior executive roles in the financial services sector in North America, culminating as Executive Vice President and a member of the Management Committee of BMO Financial Group. Prior to joining BMO Financial Group, Ms. Hanington worked for Manulife Financial/North American Life Assurance, Royal Trustco Ltd. and Suncor Inc./Sunoco Group.
Ms. Hanington currently serves as a director and as Chair of the Governance and Human Resources Committee of Aimia Inc. (TSX: AIM) and a member of the Governing Council of the University of Toronto. Ms. Hanington is the co-founder and a director of Jack.org, promoting mental health and wellness for youth in Canada since 2010, is a member of the Governing Council of the University of Toronto and is the recipient of the Meritorious Service Cross from the office of the Governor General for her work with the organization.
Ms. Hanington was named by the Women’s Executive Network (WXN)™ as one of Canada’s Top 100 Most Powerful Women three times in a row, from 2007 to 2009, and was inducted into the WXN Hall of Fame in 2010.
Ms. Hanington is a licensed professional engineer with a BASc from the University of Waterloo, an MBA from the Rotman School of Management, University of Toronto, and holds the ICD.D designation. Ms. Hanington was appointed to the Board in August 2014, and she resides in Toronto, Ontario.
Alan R. Hibben (A) (GN) (I) Independent Director, Chair of the Audit Committee
Mr. Hibben is a corporate director and advisor. Since December 2014, he has been the principal of Shakerhill Partners Ltd., a consulting firm providing strategic and financial advice, specializing in mergers and acquisitions, corporate strategy and governance, as well as expert witness services. Previously, Mr. Hibben was the Managing Director in the Mergers and Acquisitions Group at RBC Capital Markets, Head of Strategy and Development at Royal Bank of Canada and Chief Executive Officer of RBC Capital Partners.
Mr. Hibben has been a director of a number of Canadian public and private companies, both in financial services and as part of his responsibility for overseeing private equity and venture capital investments. Mr. Hibben currently serves on the respective TSX-listed boards of Home Capital Group Inc. (as Chair), Shawcor Ltd. and WildBrain Ltd. Mr. Hibben is a CPA, CA, and CFA and holds the ICD.D designation. He was appointed to the Board on January 22, 2016, and he resides in Toronto, Ontario.
Brent Houlden (A) Independent Director
Mr. Houlden is a corporate director, advisor and interim manager. Most of Mr. Houlden’s career has been spent consulting in the area of strategy and operations, and as a financial advisor on urgent business critical transactions. He is an operator and strategist with a wide breadth of management skills and consulting expertise.
After retiring as a senior Deloitte partner in November 2014, Mr. Houlden has held various management roles including being the CEO of Dealnet Capital Corp. (October 2017 to December 2020) and the Interim CFO of Danier Leather Inc. (July 2015 to April 2016).
Mr. Houlden currently serves on the board of the Mount Pleasant Group of Cemeteries. He has previously served on a number of other boards including the boards of Dealnet Capital Corp. for five years and Deloitte for six years.
Mr. Houlden is a CPA, CA and LIT, and holds an MBA from Queens University and the ICD.D designation from the Institute of Corporate Directors. Mr. Houlden was appointed to the Board on May 28, 2020, and he resides in Toronto, Ontario.
Donna E. Kingelin (HR) (QR) Independent Director, Chair of the Human Resources Committee
Ms. Kingelin is a corporate director and consultant, and is the retired owner and managing partner of Kingswood Consulting, a partnership that specialized in providing comprehensive services for seniors housing companies (2012 to 2017). She has over 30 years of leadership and operating experience in the senior living industry in public and private organizations that includes the administration of long-term care homes, retirement communities, and home health care. Previously, Ms. Kingelin held the position of Managing Director at Holiday Corporation, a private independent retirement living company (June 2010 to June 2012). Prior to that, Ms. Kingelin was a senior executive at Revera Inc. (1997 to 2010), a seniors housing company wholly owned by the Public Service Pension Investment Board (formerly TSX: RRR). Ms. Kingelin was Senior Vice President of Operations from 1997 to 2007, and Chief Operating Officer from 2007 to 2010, where she played a key role in taking the long-term care division public in 1997 as CPL Long Term Care REIT, followed by its acquisition in 2002 by RRR.
Ms. Kingelin holds board positions at Oshawa Power and Utilities Corporation (Chair of the Governance, Human Resources and Nomination Committee); Pallium Canada (Chair of the Human Resources and Nomination Committee); Kinark Child and Family Services (Chair of the Human Resources Committee); and the Kinark Foundation.
Ms. Kingelin is a Registered Nurse, holds the ICD.D designation and has completed executive management training at Queen’s University. Ms. Kingelin was appointed to the Board on January 6, 2016, and she resides in Haydon, Ontario.
Samir Manji (I) Independent Director
Mr. Manji is the founder and CEO of Sandpiper Group, a Vancouver-based real estate private equity firm established in 2016, and is the President and CEO, and a Trustee of Artis Real Estate Investment Trust. Mr. Manji has been involved in over $3 billion in hospitality, seniors housing and multifamily residential real estate transactions and has over 25 years of experience in real estate and seniors housing. Mr. Manji was the founder, Chairman and CEO of Amica Mature Lifestyles Inc. (Amica), a TSX-listed company from 1997 until its sale to the Ontario Teachers’ Pension Plan in 2015. He is a member of the Young Presidents’ Organization and he is the current President of the Ismaili Council for British Columbia. He was recognized in 2006 as a recipient of Canada’s Top 40 Under 40 and was also named the Ernst & Young Entrepreneur of the Year award winner in the business-to-consumer products and services category in British Columbia in 2010. Mr. Manji graduated from the University of Waterloo and received his CPA, CA with KPMG LLP in Toronto. He was appointed to the Extendicare Board on May 30, 2019, is the Chairman of Artis REIT, and resides in Vancouver, British Columbia.
Al Mawani (A) (HR) (I) Independent Director, Chair of the Investment Committee
Mr. Mawani is the Principal of Exponent Capital Partners Inc., a private equity investor and real estate advisory firm. He has over 35 years of experience in the commercial real estate industry, including 15 years of c-suite experience as SVP/EVP & CFO of Oxford Properties Group Inc. (1989 to 2001), President and CEO of Calloway/Smart Centres Real Estate Investment Trust (2011 to 2013), and President & CEO of privately-owned Rodenbury Investments Limited (2015 and 2016).
Mr. Mawani has been an independent board member of national and North American firms across multiple asset classes, including private-pay retirement living operations. He currently serves on the TSX-listed boards of First Capital Real Estate Investment Trust, as Chair of its Audit Committee and member of its Compensation Committee; and Granite Real Estate Investment Trust, as Chair of its Corporate Governance & Nominating Committee and as a member of its Audit Committee. In addition, he has served on the respective boards of Slate Office Real Estate Investment Trust, Boardwalk Real Estate Investment Trust, Calloway Real Estate Investment Trust, Amica Mature Lifestyles Inc., and IPC US Real Estate Investment Trust.
Mr. Mawani is a CPA, CA, and has a Masters in Law from York University, an MBA from the University of Toronto and is a member of ICD. He was appointed to the Board on December 1, 2017, and he resides in Toronto, Ontario.
A: Audit Committee
GN: Governance and Nominating Committee
HR: Human Resources Committee
I: Investment Committee
QR: Quality and Risk Committee
Honorary Directors of Extendicare
- Dr. Seth B. Goldsmith - Director Emeritus (former board member, 1995 to January 2016)
- Alvin G. Libin - Director Emeritus (former board member, 1984 to January 2016)
- J. Thomas MacQuarrie, Q.C. - Director Emeritus (former board member, 1980 to January 2016)